Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Magne™ Protein A Beads and Magne™ Protein G Beads for Antibody Purification Technical Manual

Instructions for Use of Product(s)
G7471, G7472, G7473, G8781, G8782, G8783

Literature # TM371

Magne™ Protein A Beads and Magne™ Protein G Beads are magnetic affinity beads with high specificity and high capacity for binding immunoglobulins from cell culture, ascites and serum samples. The beads have excellent magnetic properties that allow rapid and efficient capture using a variety of magnetic stands. Antibody purification can be performed using a single sample or multiple samples in parallel, with sample volumes of 20µl to 50ml.
Magne™ Protein A Beads and Protein G Beads beads use a novel attachment chemistry based on the HaloTag® technology to immobilize Protein A or Protein G. The HaloTag® protein is a multi-functional protein tag that forms a covalent bond with its ligand and is used for protein expression and purification, cell imaging, protein immobilization and protein-interaction analysis. Magne™ Protein A Beads and Magne™ Protein G Beads use recombinant Protein A from Staphylococcus and Protein G from Streptococci, respectively, fused with the HaloTag® protein. The Protein A-HaloTag® (M.Wt 71kDa) or Protein G-HaloTag® (M.Wt 58kDa) fusion protein is covalently attached in an oriented fashion to a magnetic cellulose bead that is activated using a HaloTag® ligand.
The Magne™ Protein A and Protein G Beads are not recommended for use in immunoprecipitation (IP) or co-IP applications.

Summary of Changes
At the 7/15 revision, the document design was updated. 

Printed in USA. Revised 7/15.

Experienced User Protocols